Auto-immune lymphoproliferative disorder and other secondary immune thrombocytopenias in childhood

Pediatric Blood and Cancer

Volumn 60, Issue SUPPL.1, 2013, Pages

  Price, Victoria ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Auto immune lymphoproliferative disorder; Childhood; Thrombocytopenia

Indexed keywords

CYANOCOBALAMIN; FAS LIGAND; IMMUNOGLOBULIN G; INTERLEUKIN 10; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; RITUXIMAB;

AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; CHILDHOOD DISEASE; COMMON VARIABLE IMMUNODEFICIENCY; CORTICOSTEROID THERAPY; CYTOPENIA; DISEASE ASSOCIATION; HUMAN; HYPERGAMMAGLOBULINEMIA; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE DEFICIENCY; IMMUNOGLOBULIN DEFICIENCY; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; NEUTROPENIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURPURA; REVIEW; SECONDARY IDIOPATHIC THROMBOCYTOPENIC PURPURA; SPLENECTOMY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; VACCINATION; VASCULAR DISEASE;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; APOPTOSIS; CHILD; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LYMPHOPROLIFERATIVE DISORDERS; NEUTROPENIA; THROMBOCYTOPENIA;

EID: 84869213170     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24343     Document Type: Review

References (23)

1. Choi SI, McClure PD. Idiopathic thrombocytopenic purpura in childhood. Can Med Assoc J 1967; 97: 562-568.
2. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002; 346: 995-1008.
3. Cines DB, Liebman H, Stasi R. Pathobiology of secondary immune thrombocytopenia. Semin Hematol 2009; 46: S2-S14.
4. Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010; 115: 168-186.
5. Sleasman JW. The association between immunodeficiency and the development of autoimmune disease. Adv Dent Res 1996; 10: 57-61.
6. Etzioni A. Immune deficiency and autoimmunity. Autoimmun Rev 2003; 2: 364-369.
7. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88: 3-40.
8. Neunert C, Lim W, Crowther M, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011; 117: 4190-4207.
9. Evans RS, Takahashi K, Duane RT, et al. Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology. AMA Arch Intern Med 1951; 87: 48-65.
10. Teachey DT, Manno CS, Axsom KM, et al. Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS). Blood 2005; 105: 2443-2448.
11. Seif AE, Manno CS, Sheen C, et al. Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: A multi-institutional study. Blood 2010; 115: 2142-2145.
12. Bleesing JJ, Brown MR, Novicio C, et al. A composite picture of TcR alpha/beta(+) CD4(-)CD8(-) T Cells (alpha/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome. Clin Immunol 2002; 104: 21-30.
13. Rieux-Laucat F, Le Deist F, Fischer A. Autoimmune lymphoproliferative syndromes: Genetic defects of apoptosis pathways. Cell Death Differ 2003; 10: 124-133.
14. Bleesing JJ, Straus SE, Fleisher TA. Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival. Pediatr Clin North Am 2000; 47: 1291-1310.
15. Teachey DT, Seif AE, Grupp SA. Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS). Br J Haematol 2010; 148: 205-216.
16. Fischer K, Voelkl S, Heymann J, et al. Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8-double-negative regulatory T cells. Blood 2005; 105: 2828-2835.
17. Fleisher TA, Puck JM, Strober W, et al. The autoimmune lymphoproliferative syndrome. A disorder of human lymphocyte apoptosis. Clin Rev Allergy Immunol 2001; 20: 109-120.
18. Marlies A, Udo G, Juergen B, et al. The expanded double negative T cell populations of a patient with ALPS are not clonally related to CD4+ or to CD8+ T cells. Autoimmunity 2007; 40: 299-301.
19. Oliveira JB, Bleesing JJ, Dianzani U, et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): Report from the 2009 NIH International Workshop. Blood 2010; 116: e35-e40.
20. Cunningham-Rundles C. How I treat common variable immune deficiency. Blood 2010; 116: 7-15.
21. Cheng J, Zhou T, Liu C, et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994; 263: 1759-1762.
22. Rao VK, Dugan F, Dale JK, et al. Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome. Br J Haematol 2005; 129: 534-538.
23. Teachey DT, Greiner R, Seif A, et al. Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome. Br J Haematol 2009; 145: 101-106.